CIK: 1910456 - Address: D81 Calle C, Suite 301, Pmb 1202, Dorado, PR 00646-2051
8 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
9/15/25 20:05
9/11/25
PASGPassage Bio, Inc.DEHealthBioPrdBiological Products, (No DiagLynx1 Capital Management LPPRTP.m2246.9903231,216I
7/24/25 18:12
7/22/25
PASGPassage Bio, Inc.DEHealthBioPrdBiological Products, (No DiagLynx1 Capital Management LPPRTP.m7345.700129141,068I
5/21/25 16:49
5/19/25
TCRXTscan Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLynx1 Capital Management LPPRTP.m3,1071.2002,5892114,692I
12/31/24 16:05
12/27/24
PASGPassage Bio, Inc.DEHealthBioPrdBiological Products, (No DiagLynx1 Capital Management LPPRTP2410.6451037449,257I
12/16/24 16:26
12/12/24
TCRXTscan Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLynx1 Capital Management LPPRTP.m3862.930132110,615I
11/27/24 18:11
11/25/24
PASGPassage Bio, Inc.DEHealthBioPrdBiological Products, (No DiagLynx1 Capital Management LPPRTP.m2850.62350456317,570I
11/19/24 16:26
11/15/24
TCRXTscan Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLynx1 Capital Management LPPRTP44.340105,226I
6/2/23 17:35
5/31/23
TCRXTscan Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLynx1 Capital Management LPPRTS-642.520-25010,465I

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact